About this trial
The objectives of this multicenter, prospective, observational study were to investigate the incidence of dyspeptic symptoms in patients with Helicobacter pylori (H. pylori) infection and to continuously follow up the remission of dyspeptic symptoms after H. pylori eradication, so as to provide reference for the clinical diagnosis and treatment strategies of patients with H. pylori infection and dyspeptic symptoms.
Eligibility criteria
Qualifiers
Male or female patients aged 18-80 years
H. pylori infection diagnosed by 13C/ 14C-UBT (> 2 times the cutoff value) and/or gastroscopy (rapid urease strong positive and histological positive)
Treatment-naive patients with Helicobacter pylori
Ability and willingness to participate in the study and to sign and give informed consent
Disqualifiers
Under 18 or over 80 years old
Organic digestive diseases, such as active peptic ulcer, gastroesophageal reflux, gastrointestinal bleeding, acute/chronic pancreatitis, acute/chronic cholecystitis, gallstones, intestinal obstruction, inflammatory bowel disease, etc.
Combined with melena, hematemesis, anemia, emaciation and other alarm symptoms
Pregnant and lactating women
Trial design
Treatments tested in this trial
- Epidemiological questionnaire and Functional Dyspepsia Symptom Diary(FDSD)
Treatment groups
Sponsors and collaborators
Shanghai Jiao Tong University School of Medicine
Lead sponsor
RenJi Hospital
Sponsor institution